Haplotype analysis of signal peptide (insertion/deletion) and Xba I polymorphisms of the APOB gene in gallbladder cancer

Liver International

Volumn 27, Issue 7, 2007, Pages 1008-1015

  Pandey, Sachchida Nand ^a   Srivastava, Anvesha ^a   Dixit, Manjusha ^a   Choudhuri, Gourdas ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

APOB; Cholesterol; Gallbladder cancer; Gallstone; Haplotype; Ins del polymorphism; Xba polymorphism

Indexed keywords

APOLIPOPROTEIN B; SIGNAL PEPTIDE;

ADULT; ALGORITHM; ARTICLE; ASPIRATION BIOPSY; CASE CONTROL STUDY; CHOLELITHIASIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; GALLBLADDER CANCER; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; FEMALE; GALLBLADDER NEOPLASMS; GALLSTONES; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROTEIN SORTING SIGNALS; RISK ASSESSMENT; RISK FACTORS;

EID: 34547918344     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01516.x     Document Type: Article

References (39)

1. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-76.
2. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 349-64.
3. Scragg RK, Mcmicheal AJ, Baghurst PA. Diet alcohol and relative weight in gallstone disease: A case-control study. BMJ 1984; 288: 1113-8.
4. Mohr GC, Kritz-Silverstein D, Barrette-Connor E. Plasma lipid and gallbladder disease. Am J Epidemol 1991; 134: 78-85.
5. Thijis C, Knipschild P, Brombacher P. Serum lipid and gallstones: A case control study. Gastroenterology 1990; 99: 843-9.
6. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997; 26: 809-18.
7. Yang CY, Gu ZW, Weng SA, et al. Structure of apolipoprotein B-100 of human low density lipoproteins. Arterioscler Thromb Vasc Biol 1989; 9: 96-108.
8. Demmer LA, Levin MS, Elovson J, Reuben MA, Lusis AJ, Gordon JI. Tissue-specific expression and developmental regulation of the rat apolipoprotein B gene. Proc Natl Acad Sci USA 1986; 83: 8102-6.
9. Regis-Bailly A, Visvikis S, Steinmetz J, et al. Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population. Clin Genet 1996; 50: 339-47.
10. Han T, Jiang Z, Suo G, Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet 2000; 57: 304-8.
11. Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesaniemi YA. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995; 36: 804-12.
12. Vedie B, Myara I, Jeunemaitre X, Moatti N. Variations génétiques du gène de l'apolipoproteine B. Ann Génet 1995; 38: 187-201.
13. Jemaa R, Mebazaa A, Fumeron F. Polymorphism insertion/deletion of apolipoprotein B gene: Effect on lipid levels in obese patients. Ann Biol Clin (Paris) 2004; 62: 183-8.
14. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 349-64.
15. Bearhs OH, Henson DE, Hutter RVP. Manual for Staging of Cancer, 3rd edn. Philadelphia, PA: Lippincott, 1988.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
17. Boerwinkle E, Xiong WJ, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 1989; 86: 212-6.
18. Merten, Thomas R. Introducing students to population genetics and the Hardy-Weinberg principle. Am Biol Teacher 1997; 103-7.
19. Mishra NC, Mishra S, Chaturvedi A. Carcinoma gallbladder. In: Johnson CD, Taylor I, eds. Recent Advances in Surgery, Vol. 20. London: Churchill Livingstone, 1997; 69-87.
20. Lambert M, Assouline L, Carlos J, et al. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2001; 21: 979-84.
21. Sama C, Lambate AMM, Taroni F, Barbara L. Epidemiology and natural history of gallstone disease. Semin Liver Dis 1990; 10: 149-58.
22. Singh MK, Pandey UB, Ghoshal UC, et al. Apolipoprotein B-100 Xba I gene polymorphism in gallbladder cancer. Hum Genet 2004; 114: 280-3.
23. Regis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G, Visvikis S. Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 1995; 118: 23-34.
24. Schonfeld G. Genetic variation of apolipoprotein B can produce both low and high levels of apoB-containing lipoproteins in plasma. Can J Cardiol 1995; 11: 86-92.
25. Bohn M, Bakken A, Erikssen J, Berg K. The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin Genet 1994; 45: 255-9.
26. Hixson JE, Mcmahan A, Mcgill HC Jr, Strong JP. ApoB insertion: Deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arterioscler Thromb 1992; 12: 1023-9.
27. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The shibata study. Arterioscler Thromb Vasc Biol 1997; 17: 3495-504.
28. Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, Kesäniemi YA. Apolipoprotein B gene polymorphisms and serum lipids: Meta-analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr 2000; 71: 713-24.
29. Pajukanta PE, Valstab LM, Arob A, Pietinenb P, Heliö T, Tikkanen MJ. The effects of the apolipoprotein B signal peptide (ins/del) and Xba I polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 1996; 122: 1-10.
30. Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
31. Tall AR, Costel P, Wang N. Regulation and mechanism of macrophage cholesterol efflux. J Clin Invest 2002; 110: 899-904.
32. Boyd NFV. Evidence of association between plasma high density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 1990; 21: 460-8.
33. Bordeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastoma correlates with advance disease stage. Science 1984; 224: 1121-4.
34. Yoder JA, Yen RW, Vertino PM, Bestor TH, Baylin SB. New, 5′ regions of the murine and human gene for DNA (cytosine-5)-methyltransferase. J Biol Chem 1996; 271: 31092-7.
35. Pensotti V, Radice P, Prescituttini S, et al. Mean age of tumour onset in heriditary nonpolyposis colorectal cancer (HNPCC) families correlate with the presence of mutation in DNA mitchmatch repair gene. Genes Chromosome Cancer 1997; 19: 135-42.
36. Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 2003; 1637: 1-19.
37. Dixit M, Choudhuri G, Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig Liver Dis 2006a; 38: 397-403.
38. Dixit M, Choudhuri G, Keshri LJ, Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol 2006b; 21: 847-9.
39. Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007; 27: 109-21.